Zhang Chengzhi, Yan Guiying
Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing 100190, PR China.
School of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing, 100049, PR China.
Synth Syst Biotechnol. 2019 Feb 7;4(1):67-72. doi: 10.1016/j.synbio.2018.10.002. eCollection 2019 Mar.
There is compelling evidence that synergistic drug combinations have become promising strategies for combating complex diseases, and they have evident predominance comparing to traditional one drug - one disease approaches. In this paper, we develop a computational method, namely SyFFM, that takes pharmacological data into consideration and applies field-aware factorization machines to analyze and predict potential synergistic drug combinations. Firstly, features of drug pairs are constructed based on associations between drugs and target, and enzymes, and indication areas. Then, the synergistic scores of drug combinations are obtained by implementing field-aware factorization machines on latent vector space of these features. Finally, synergistic combinations can be predicted by introducing a threshold. We applied SyFFM to predict pairwise synergistic combinations and three-drug synergistic combinations, and the performance is good in terms of cross-validation. Besides, more than 90% combinations of the top ranked predictions are proved by literature and the analysis of parameters in model shows that our method can help to investigate and explain synergistic mechanisms underlying combinatorial therapy.
有令人信服的证据表明,协同药物组合已成为对抗复杂疾病的有前景的策略,并且与传统的一药治一病方法相比,它们具有明显的优势。在本文中,我们开发了一种计算方法,即SyFFM,该方法考虑了药理学数据,并应用领域感知因子分解机来分析和预测潜在的协同药物组合。首先,基于药物与靶点、酶以及适应症领域之间的关联构建药物对的特征。然后,通过在这些特征的潜在向量空间上实现领域感知因子分解机来获得药物组合的协同分数。最后,通过引入阈值来预测协同组合。我们将SyFFM应用于预测成对协同组合和三药协同组合,并且在交叉验证方面表现良好。此外,排名靠前的预测中超过90%的组合得到了文献的证实,并且对模型参数的分析表明,我们的方法有助于研究和解释联合治疗背后的协同机制。